Constructs binding to phosphatidylserine and their use in disease treatment

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8956616
APP PUB NO 20060228299A1
SERIAL NO

11339392

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are new phosphatidylserine binding constructs with surprising combinations of properties, and a range of diagnostic and therapeutic conjugates thereof. The new constructs effectively bind phosphatidylserine targets in disease and enhance their destruction, and can also specifically deliver attached imaging or therapeutic agents to the disease site. Also disclosed are methods of using the new construct compositions, therapeutic conjugates and combinations thereof in tumor vasculature targeting, cancer diagnosis and treatment, and for treating viral infections and other diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MIDCAP FUNDING III LLC7735 OLD GEORGETOWN ROAD SUITE 400 BETHESDA MD 20814

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
King, Steven W Ladera Ranch, US 15 266
Luster, Troy A Dallas, US 3 32
Thorpe, Philip E Dallas, US 83 3931

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 17, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00